Evidence map›Paper›PMID 39062517›Full record

ReviewBiomolecules2024

The Role of the RNA Helicase DDX3X in Medulloblastoma Progression.

Akanksha Swarup, Timothy A Bolger

Abstract readReview
In one paragraph

Review in Biomolecules, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Akanksha SwarupDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.
Timothy A BolgerDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, GA 30602, USA.ORCID 0000-0001-9526-4110

Funding

Regulation of the Translational Response to Cellular StressR01GM136827 · NIGMS · UNIVERSITY OF GEORGIA · PI BOLGER, TIMOTHY A · 2020 to 2024
$1.5M
NIGMS NIH HHS R01 GM136827NIH HHS R01-GM136827-06
6 · The paper itself

Abstract

Medulloblastoma is the most common pediatric brain cancer, with about five cases per million in the pediatric population. Current treatment strategies have a 5-year survival rate of 70% or more but frequently lead to long-term neurocognitive defects, and recurrence is relatively high. Genomic sequencing of medulloblastoma patients has shown that

Indexed as

DEAD-box RNA HelicasesDisease ProgressionMedulloblastomaMutationAnimalsCerebellar NeoplasmsHumansSaccharomyces cerevisiae ProteinsDDX3X protein, humanDEAD-box RNA HelicasesDED1 protein, S cerevisiaeSaccharomyces cerevisiae ProteinsDDX3XmedulloblastomaRNA helicasetranslation

Identifiers

PMID39062517
PMCPMC11274571

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.